Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 14;4(3):795-811.
doi: 10.3390/biom4030795.

Interactions between calcium and alpha-synuclein in neurodegeneration

Affiliations
Review

Interactions between calcium and alpha-synuclein in neurodegeneration

Alex Rcom-H'cheo-Gauthier et al. Biomolecules. .

Abstract

In Parkinson's disease and some atypical Parkinson's syndromes, aggregation of the α-synuclein protein (α-syn) has been linked to neurodegeneration. Many triggers for pathological α-syn aggregation have been identified, including port-translational modifications, oxidative stress and raised metal ions, such as Ca2+. Recently, it has been found using cell culture models that transient increases of intracellular Ca2+ induce cytoplasmic α-syn aggregates. Ca2+-dependent α-syn aggregation could be blocked by the Ca2+ buffering agent, BAPTA-AM, or by the Ca2+ channel blocker, Trimethadione. Furthermore, a greater proportion of cells positive for aggregates occurred when both raised Ca2+ and oxidative stress were combined, indicating that Ca2+ and oxidative stress cooperatively promote α-syn aggregation. Current on-going work using a unilateral mouse lesion model of Parkinson's disease shows a greater proportion of calbindin-positive neurons survive the lesion, with intracellular α-syn aggregates almost exclusively occurring in calbindin-negative neurons. These and other recent findings are reviewed in the context of neurodegenerative pathologies and suggest an association between raised Ca2+, α-syn aggregation and neurotoxicity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
α-Synuclein protein (α-syn) domain structure. α-Syn contains three putative domains. KTK repeats in the N-terminus are involved in lipid interaction, the hydrophobic NAC domain is important for aggregation and the C-terminal Ca2+ binding site can increase the rate of oligomerization [1,2]. The Parkinson’s disease (PD)-linked point mutations are indicated within the neurotransmitter vesicle binding domain.
Figure 2
Figure 2
Raised intracellular Ca2+ promotes α-syn aggregation. (A) 1321N1 human glioma cells treated with either thapsigargin or Ca2+ ionophore caused raised intracellular free Ca2+ and induced α-syn aggregates (arrows) after 12–24 h [80]; (B) Potassium depolarization of SH-SY5Y human neuroblastoma and HEK293T cells resulted in transiently raised intracellular free Ca2+ and Lewy body-like large α-syn aggregates (arrows) that could be blocked by the BAPTA-AM Ca2+ chelator [81]. (C) Co-treatment of 1321N1 cells with thapsigargin (TG) or Ca2+ ionophore (CI) and hydrogen peroxide resulted in increased α-syn aggregates (arrows; graph, right); consistent with a cooperative interaction between raised free Ca2+ and oxidative stress [87]. Scale bars, 10 μm.
Figure 3
Figure 3
Unilateral rotenone lesion mouse (oxidative stress) model of PD shows α-syn aggregates primarily in calbindin-negative neurons. (A) CB+ neurons (arrowheads) showed relative protection in the unilateral rotenone lesion (oxidative stress) model of PD (as detailed in [85]), with more CB+ neurons surviving in the treated than in the untreated hemisphere and partitioning of α-syn aggregates (arrow) in the CB− neurons [86]. Scale bar, 50 μm. (B) Graph of cell counting data shows a significantly greater number of α-syn aggregates occur in CB− neurons than in CB+ neurons.

References

    1. Goedert M., Spillantini M.G., del Tredici K., Braak H. 100 years of Lewy pathology. Nat. Rev. Neurol. 2013;9:13–24. doi: 10.1038/nrneurol.2012.242. - DOI - PubMed
    1. Eschbach J., Danzer K.M. α-Synuclein in Parkinson’s disease: Pathogenic function and translation into animal models. Neurodegener. Dis. 2014;14:1–17. doi: 10.1159/000354615. - DOI - PubMed
    1. Radford R., Wong M.B., Pountney D.L. Neurodegenerative aspects of multiple system atrophy. In: Kostrzewa R.M., editor. Handbook of Neurotoxicity. Springer; New York, NY, USA: 2014. pp. 2157–2180.
    1. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat. Genet. 1998;18:106–108. - PubMed
    1. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047. - PubMed

Publication types